Rhopressa Solution/ Drops
NDC Package 70727-497-99
Package Information
Rhopressa (netarsudil) solution/ dropses is netarsudil is used to treat high pressure inside the eye due to certain eye conditions (such as open-angle glaucoma, ocular hypertension). This formulation utilizes a solution/ drops delivery system. Marketed by Alcon Laboratories, Inc., this product is identified by NDC 70727-497 and is authorized under FDA application NDA208254.
Identification & Billing
- RxCUI: 1992868 - netarsudil 0.02 % Ophthalmic Solution
- RxCUI: 1992868 - netarsudil 0.2 MG/ML Ophthalmic Solution
- RxCUI: 1992868 - netarsudil 0.2 MG/ML (as netarsudil dimesylate 0.28 MG/ML) Ophthalmic Solution
- RxCUI: 1992873 - Rhopressa 0.02 % Ophthalmic Solution
- RxCUI: 1992873 - netarsudil 0.2 MG/ML Ophthalmic Solution [Rhopressa]
Clinical Specifications
- Ophthalmic - Administration to the external eye.
- Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Regulatory & Marketing
Hierarchy Structure
- 70727 - Alcon Laboratories, Inc.
- 70727-497 - Rhopressa
- 70727-497-99 - 1 BOTTLE in 1 CARTON / 2.5 mL in 1 BOTTLE
- 70727-497 - Rhopressa
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (70727-497). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 70727-497-99 identifies a specific commercial package of 1 bottle in 1 carton / 2.5 ml in 1 bottle of Rhopressa, a human prescription drug labeled by Alcon Laboratories, Inc.. This solution/ drops is formulated for ophthalmic; topical use and contains netarsudil mesylate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Alcon Laboratories, Inc. on December 18, 2017. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
Netarsudil is used to treat high pressure inside the eye due to certain eye conditions (such as open-angle glaucoma, ocular hypertension). This medication is thought to work by increasing the flow of fluid out of the eye. This helps lower pressure inside the eye. Lowering high pressure inside the eye can help prevent loss of vision or blindness.
How is this Alcon Laboratories, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 70727049799. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.